There were 680 press releases posted in the last 24 hours and 156,628 in the last 365 days.

The Anti-Infective Drugs Market Value Is Expected To Reach $116 Billion By 2022

The Business Research Company adds Anti-Infective Drugs Market By Type Of Products, By Opportunities And Strategies – Global Forecast To 2022 to its store.

Players In The Anti-Infective Drugs Market Include Gilead Sciences, Glaxosmithkline, Merck & Co., Teva Pharmaceuticals And Johnson & Johnson.”
— Abdul Wasay

LONDON, GREATER LONDON, UK, June 3, 2019 /EINPresswire.com/ -- The global market for anti-infective drugs is expected to reach a value of nearly above $115 billion by 2022, having grown at an annual rate of above 6% since 2018.

Growth in the historic period resulted from the rise in incidence rate of infectious diseases, aging population and growth in emerging markets. Going forward, the global economic growth and developments in drug discovery procedures will drive growth of the market. Factors that negatively affected growth in the historic period were patent expiration of drugs, pricing pressures from regulators, and low return on Investment in the anti-infective drugs industry. Factors that could hinder the growth of this market in the future are results of the global antimicrobial resistance, shortage of anti-infective drugs and reduction in free trade.

Request For A Free Sample For The Global Anti-Infective Drugs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2348&type=smp

The market can be segmented by type into antibiotics, antivirals, antifungals and others (including anthelminthic and antiprotozoal drugs). The antivirals market accounted for the largest share of the anti-infective drugs market in 2018 at 43.1% mainly supported by a high prevalence rate of viral infections worldwide, especially in developing countries, such as diarrhoeal disease and continuous treatment required by patients suffering with untreatable viral diseases such as HIV/AIDS, Hepatitis B and others. This market is also expected to be the fastest-growing segment going forward at a CAGR of 8.2%.

North America is the largest market for anti-infective drugs manufacturing companies, accounting for 47.7% of the global market and mainly supported by the presence of a large patient pool in the region, high prevalence rate of diseases such as tuberculosis, influenza, and HIV/AIDS, and high medical expenditure and insurance coverage in countries such as the USA and Canada. It was followed by Western Europe, Asia-Pacific and then the other regions. Going forward, Africa and the Middle East will be the fastest growing regions in this market, where growth will be at a CAGR of 12.5% and 9.1% respectively. They are expected to be followed by Asia-Pacific and South America where the market is expected to grow at a CAGR of 8.9% and 6.3% respectively.

Read More On The Report For The Global Anti-Infective Drugs Market At:
https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-market

Major players in the market include Gilead Sciences, GlaxosmithKline, Merck & Co., Teva Pharmaceuticals and Johnson & Johnson.

Anti-Infective Drugs Market By Type Of Product (Antibiotics, Antivirals, Antifungals And Others (Including Anthelminthic And Antiprotozoal Drugs), Opportunities And Strategies – Global Forecast To 2022 is one of a series of new reports from The Business Research Company that provides anti-infective drugs market overviews, analyzes and forecasts anti-infective drugs market size and growth for the global anti-infective drugs market, anti-infective drugs market share, anti-infective drugs market players, anti-infective drugs market size, anti-infective drugs market segments and geographies, anti-infective drugs market trends, anti-infective drugs market drivers and anti-infective drugs market restraints, anti-infective drugs market’s leading competitors’ revenues, profiles and market shares. The anti-infective drugs market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Where To Learn More
Read Anti-Infective Drugs Market By Type Of Product (Antibiotics, Antivirals, Antifungals And Others (Including Anthelminthic And Antiprotozoal Drugs), Opportunities And Strategies – Global Forecast To 2022 from The Business Research Company for information on the following:

Markets Covered: global anti-infective drugs market and segments, antibiotics, antivirals, antifungals and others (including anthelminthic and antiprotozoal drugs)

Data Segmentations: anti-infective drugs market size, global and by country; historic and forecast size, and growth rates for the world, 7 regions and 12 countries

Anti-Infective Drugs Market Organizations Covered: Gilead Sciences, GlaxosmithKline, Merck & Co., Teva Pharmaceuticals and Johnson & Johnson.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Time Series: Five years historic (2014-18) and forecast (2018-22).

Other Information And Analyses: PESTEL analysis, anti-infective drugs market customer information, anti-infective drugs market product/service analysis – product examples, anti-infective drugs market trends and opportunities, drivers and restraints, key mergers and acquisitions, global anti-infective drugs market in 2019 - countries offering most new opportunities

Sourcing and Referencing: Data and analysis throughout the report are sourced using end notes.

Strategies For Participants In The Anti-Infective Drugs Industry: The report explains a number of strategies for companies in the anti-infective drugs market, based on industry trends and company analysis.

Opportunities For Companies In The Anti-Infective Drugs Sector: The report reveals where the global Anti-Infective Drugs industry will put on most $ sales up to 2022.

Interested to know more about The Business Research Company?
The Business Research Company has published over 300 industry reports, covering over 2400 market segments and 56 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. Here is a list of reports from The Business Research Company similar to Anti-Infective Drugs Market By Type Of Product (Antibiotics, Antivirals, Antifungals And Others (Including Anthelminthic And Antiprotozoal Drugs), Opportunities And Strategies – Global Forecast To 2022:

Pharmaceutical Drugs Market By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs) - Global Forecast To 2022

Biologics Market By Types (Monoclonal Antibodies, Therapeutic Proteins And Vaccines), By Trends, By Regions And By Key Players - Global Forecast To 2021

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.